TORward AKTually useful mouse models

Nat Med. 2004 Jun;10(6):579-80. doi: 10.1038/nm0604-579.
No abstract available

Publication types

  • News
  • Comment

MeSH terms

  • Animals
  • Antineoplastic Agents* / chemistry
  • Antineoplastic Agents* / therapeutic use
  • Disease Models, Animal
  • Everolimus
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Mice
  • Mice, Transgenic
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism
  • Protein Kinases / genetics
  • Protein Kinases / metabolism*
  • Protein Serine-Threonine Kinases / genetics
  • Protein Serine-Threonine Kinases / metabolism*
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins / metabolism*
  • Proto-Oncogene Proteins c-akt
  • Sirolimus / analogs & derivatives
  • Sirolimus / therapeutic use*
  • TOR Serine-Threonine Kinases

Substances

  • Antineoplastic Agents
  • Immunosuppressive Agents
  • Proto-Oncogene Proteins
  • Everolimus
  • Protein Kinases
  • MTOR protein, human
  • mTOR protein, mouse
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-akt
  • TOR Serine-Threonine Kinases
  • Sirolimus